Drugs giant AstraZeneca has abandoned plans to seek approval for its Covid-19 jab in the US as it revealed falling sales of the vaccine worldwide.The Anglo-Swedish group, which developed the Vaxzevria vaccine with Oxford University, revealed in its third-quarter results that it would drop an application with the Food and Drug Administration (FDA) in the US and instead focus its efforts elsewhere globally, including for its use as a booster.
[
add
]
[
|
|
...
]